Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zannetti

Showing results (181-190 of 264) with videos related to

Pageof 27
Sort By:
Nanotechnology|April 27, 2016
In situ growth of Ag nanoparticles on α-Ag2WO4 under electron irradiation: probing the physical principlesMiguel A San-Miguel, Edison Z da Silva, Sonia M Zannetti, et al.
Plos One|March 22, 2013
1,25-Dihydroxyvitamin D3 suppresses TLR8 expression and TLR8-mediated inflammatory responses in monocytes in vitro and experimental autoimmune encephalomyelitis in vivoBo Li, David J Baylink, Chandra Deb, et al.
Cells|December 16, 2020
Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma ModelBeatrice Anna Zannetti, Angelo Corso Faini, Evita Massari, et al.
Journal of Medicinal Chemistry|May 26, 2006
Novel and selective alpha(v)beta3 receptor peptide antagonist: design, synthesis, and biological behaviorAnnarita Del Gatto, Laura Zaccaro, Paolo Grieco, et al.
Cancers|January 27, 2019
Therapeutic Potential of a Novel α<sub>v</sub>β₃ Antagonist to Hamper the Aggressiveness of Mesenchymal Triple Negative Breast Cancer Sub-TypeBilly Samuel Hill, Annachiara Sarnella, Domenica Capasso, et al.
Annals of Hematology|September 9, 2011
Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myelomaElena Zamagni, Alessandro Petrucci, Patrizia Tosi, et al.
Journal of Medicinal Chemistry|November 17, 2017
Chemical Modification for Proteolytic Stabilization of the Selective α<sub>v</sub>β<sub>3</sub> Integrin RGDechi Peptide: in Vitro and in Vivo Activities on Malignant Melanoma CellsDaniela Comegna, Antonella Zannetti, Annarita Del Gatto, et al.
Cancer Research|October 28, 1999
Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancerM V Carriero, S Del Vecchio, M Capozzoli, et al.
Journal of Vascular Surgery|January 22, 2000
Eversion versus conventional carotid endarterectomy: late results of a prospective multicenter randomized trialP Cao, G Giordano, P De Rango, et al.
Plos One|November 3, 2011
Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cellsIsabelle E Vincent, Claudia Zannetti, Julie Lucifora, et al.
Pageof 27

Showing results (181-190 of 264) with videos related to

Sort By:
Pageof 27
Nanotechnology|April 27, 2016
In situ growth of Ag nanoparticles on α-Ag2WO4 under electron irradiation: probing the physical principlesMiguel A San-Miguel, Edison Z da Silva, Sonia M Zannetti, et al.
Plos One|March 22, 2013
1,25-Dihydroxyvitamin D3 suppresses TLR8 expression and TLR8-mediated inflammatory responses in monocytes in vitro and experimental autoimmune encephalomyelitis in vivoBo Li, David J Baylink, Chandra Deb, et al.
Cells|December 16, 2020
Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma ModelBeatrice Anna Zannetti, Angelo Corso Faini, Evita Massari, et al.
Journal of Medicinal Chemistry|May 26, 2006
Novel and selective alpha(v)beta3 receptor peptide antagonist: design, synthesis, and biological behaviorAnnarita Del Gatto, Laura Zaccaro, Paolo Grieco, et al.
Cancers|January 27, 2019
Therapeutic Potential of a Novel α<sub>v</sub>β₃ Antagonist to Hamper the Aggressiveness of Mesenchymal Triple Negative Breast Cancer Sub-TypeBilly Samuel Hill, Annachiara Sarnella, Domenica Capasso, et al.
Annals of Hematology|September 9, 2011
Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myelomaElena Zamagni, Alessandro Petrucci, Patrizia Tosi, et al.
Journal of Medicinal Chemistry|November 17, 2017
Chemical Modification for Proteolytic Stabilization of the Selective α<sub>v</sub>β<sub>3</sub> Integrin RGDechi Peptide: in Vitro and in Vivo Activities on Malignant Melanoma CellsDaniela Comegna, Antonella Zannetti, Annarita Del Gatto, et al.
Cancer Research|October 28, 1999
Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancerM V Carriero, S Del Vecchio, M Capozzoli, et al.
Journal of Vascular Surgery|January 22, 2000
Eversion versus conventional carotid endarterectomy: late results of a prospective multicenter randomized trialP Cao, G Giordano, P De Rango, et al.
Plos One|November 3, 2011
Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cellsIsabelle E Vincent, Claudia Zannetti, Julie Lucifora, et al.
Pageof 27